Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 146,156
  • Shares Outstanding, K 47,920
  • Annual Sales, $ 20 K
  • Annual Income, $ -16,100 K
  • 60-Month Beta 1.68
  • Price/Sales 8.72
  • Price/Cash Flow N/A
  • Price/Book 6.87

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.16
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.94 +1.11%
on 09/21/20
3.63 -18.07%
on 08/25/20
-0.49 (-14.16%)
since 08/21/20
3-Month
2.94 +1.11%
on 09/21/20
5.20 -42.88%
on 07/14/20
-0.92 (-23.65%)
since 06/22/20
52-Week
2.22 +33.78%
on 03/18/20
6.84 -56.58%
on 09/26/19
-1.80 (-37.74%)
since 09/20/19

Most Recent Stories

More News
VolitionRx Limited to Present at Conferences in September 2020

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, , and its Executive Vice President, Investor Relations, , are scheduled to present...

VNRX : 2.95 (-3.28%)
VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended . Volition management will host a conference...

VNRX : 2.95 (-3.28%)
VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on , at to discuss its financial and operating results for the second quarter 2020,...

VNRX : 2.95 (-3.28%)
49 Public Companies to Present at the SNN Network Virtual Conference on August 3-6, 2020

The SNN Network Virtual Conference will take place on August 3 - 6, 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience.

AIM : 2.50 (+22.55%)
AZT.VN : 0.460 (-4.17%)
DUOT : 3.78 (+0.80%)
SOLO : 2.54 (-0.78%)
EFOI : 7.42 (+4.51%)
ESK.VN : 0.800 (-1.23%)
EXROF : 1.0000 (+6.45%)
XRO.CN : 1.240 (+5.98%)
CALI.CN : 0.080 (+14.29%)
FNNZF : 0.0531 (-18.18%)
FBIO : 4.40 (-5.78%)
GIGA : 4.1500 (-0.24%)
HBP.TO : 0.3900 (-4.88%)
IDEX : 0.9235 (-4.79%)
ISDR : 18.20 (+16.97%)
LXXGF : 0.6436 (-0.98%)
OSS.VN : 0.680 (-2.86%)
RDHL : 10.40 (+1.76%)
REKR : 7.06 (-0.28%)
SZLS.TO : 1.07 (+1.90%)
TBP.VN : 0.215 (+2.38%)
TNXP : 0.9283 (-0.18%)
URG : 0.5224 (+2.43%)
GROW : 2.57 (-1.53%)
VNRX : 2.95 (-3.28%)
WWR : 1.6200 (-8.47%)
VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes

, /PRNewswire/ --  (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases,...

VNRX : 2.95 (-3.28%)
Global Care Capital Inc Closes Acquisition of 70% Interest in High Standard Health Care Generating $4 Million with 40% Gross Margin in Orders to Date

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VNRX : 2.95 (-3.28%)
Global Care Capital Inc. Signs Definitive Agreement to Acquire 70% Interest in High Standard Health Care Generating $4 Million With 40% Gross Margin in Orders to Date

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VNRX : 2.95 (-3.28%)
Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference

, /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that President and Chief Executive Officer, has been invited to present at Conference organised by the Maxim Group....

VNRX : 2.95 (-3.28%)
Global Care Capital Inc. Announces Non-Binding LOI to Acquire 70% Interest in High Standard Health Care Generating $4 Million in Orders to Date

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

VNRX : 2.95 (-3.28%)
VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock

, /PRNewswire/ -- (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy to use, cost-effective...

VNRX : 2.95 (-3.28%)
NHLD : 2.17 (+1.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade VNRX with:

Business Summary

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer...

See More

Key Turning Points

2nd Resistance Point 3.21
1st Resistance Point 3.13
Last Price 2.95
1st Support Level 2.95
2nd Support Level 2.86

See More

52-Week High 6.84
Fibonacci 61.8% 5.08
Fibonacci 50% 4.53
Fibonacci 38.2% 3.98
Last Price 2.95
52-Week Low 2.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar